Correction to: Leukemia
Following the publication of this article, the authors noted a minor error in the patient numbers on the lower axis of Fig. 4, panel A. This has now been corrected and the amended figure included below. This error does not impact the scientific validity of the manuscript or any conclusions drawn in it.
Author information
Authors and Affiliations
Corresponding author
Additional information
The original article can be found online at https://doi.org/10.1038/s41375-021-01261-x.
Rights and permissions
About this article
Cite this article
Cervantes, F., Ross, D.M., Radinoff, A. et al. Correction: Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study. Leukemia 35, 3626 (2021). https://doi.org/10.1038/s41375-021-01396-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41375-021-01396-x
